Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

MPL antibody

MPL Reactivity: Human WB, FACS, EIA Host: Mouse Monoclonal 1H2 unconjugated
Catalog No. ABIN1105749
  • Target See all MPL Antibodies
    MPL (Myeloproliferative Leukemia Virus Oncogene (MPL))
    Reactivity
    • 55
    • 27
    • 23
    • 1
    • 1
    Human
    Host
    • 52
    • 6
    Mouse
    Clonality
    • 54
    • 4
    Monoclonal
    Conjugate
    • 18
    • 4
    • 4
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    This MPL antibody is un-conjugated
    Application
    • 38
    • 34
    • 16
    • 13
    • 13
    • 9
    • 5
    • 4
    • 4
    • 3
    • 2
    • 1
    Western Blotting (WB), Flow Cytometry (FACS), Enzyme Immunoassay (EIA)
    Specificity
    Recognizes MPL/CD110
    Cross-Reactivity (Details)
    Species reactivity (tested):Human.
    Purification
    Purified
    Clone
    1H2
    Isotype
    IgG2b
    Top Product
    Discover our top product MPL Primary Antibody
  • Application Notes
    Optimal working dilution should be determined by the investigator.
    Restrictions
    For Research Use only
  • Format
    Liquid
    Concentration
    1.0 mg/mL
    Buffer
    PBS, 0.05 % Sodium Azide, 0.5 % protein stabilizer
    Preservative
    Sodium azide
    Precaution of Use
    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
  • Target
    MPL (Myeloproliferative Leukemia Virus Oncogene (MPL))
    Alternative Name
    CD110 (MPL Products)
    Synonyms
    C-MPL antibody, CD110 antibody, MPLV antibody, THCYT2 antibody, TPOR antibody, TPO-R antibody, c-mpl antibody, c-mpl-I antibody, c-mpl-II antibody, hlb219 antibody, MPL antibody, mpll antibody, tpor antibody, tpor.b antibody, MPL proto-oncogene, thrombopoietin receptor antibody, myeloproliferative leukemia virus oncogene antibody, MPL antibody, Mpl antibody, mpl antibody
    Background
    In 1990 an oncogene, v-mpl, was identified from the murine myeloproliferative leukemia virus that was capable of immortalizing bone marrow hematopoietic cells from different lineages. In 1992 the human homologue, named, c-mpl, was cloned. Sequence data revealed that c-mpl encoded a protein that was homologous with members of the hematopoietic receptor superfamily. Presence of anti-sense oligodeoxynucleotides of c-mpl inhibited megakaryocyte colony formation. The ligand for c-mpl, thrombopoietin, was cloned in 1994. Thrombopoietin was shown to be the major regulator of megakaryocytopoiesis and platelet formation. The protein encoded by the c-mpl gene, CD110, is a 635 amino acid transmembrane domain, with two extracellular cytokine receptor domains and two intracellular cytokine receptor box motifs . TPO-R deficient mice were severely thrombocytopenic, emphasizing the important role of CD110 and thrombopoietin in megakaryocyte and platelet formation. Upon binding of thrombopoietin CD110 is dimerized and the JAK family of non-receptor tyrosine kinases, as well as the STAT family, the MAPK family, the adaptor protein Shc and the receptors themselves become tyrosine phosphorylated.Synonyms: MPL, Myeloproliferative leukemia protein, TPO-R, TPOR
    Molecular Weight
    71.2 kDa
    Gene ID
    4352
    Pathways
    JAK-STAT Signaling
You are here:
Support